-14.35% percent quarterly performance for EyePoint Pharmaceuticals Inc (EYPT) is not indicative of the underlying story
On Friday, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) was -0.28% drop from the session before settling in for the closing price of $7.12. A 52-week range